Literature DB >> 18568562

Bilateral pulvinar signal intensity decrease on T2-weighted images in patients with aspartylglucosaminuria.

T Autti1, T Lönnqvist, R Joensuu.   

Abstract

BACKGROUND: Aspartylglucosaminuria (AGU) is an autosomal recessive lysosomal disease caused by deficiency of aspartylglucosaminidase. A thalamic T2 signal intensity decrease is associated with lysosomal diseases.
PURPOSE: To investigate thalamic signal intensity in AGU by performing a retrospective review of brain magnetic resonance (MR) imaging studies of AGU patients.
MATERIAL AND METHODS: A total of 25 MR examinations were available for 11 patients aged between 3 and 32 years (four patients underwent bone marrow transplantation). Of these, 13 examinations were performed after bone marrow transplantation. Five patients had from two to six examinations, and six patients had one examination each. In every patient, the diagnosis of AGU was confirmed by blood and urine tests. Eighteen examinations were performed with a 1.0T imager including dual spin-echo T2 and proton density (PD) axial and coronal images, and 10 examinations also included T1-weighted images. Seven examinations were performed with a 1.5T imager including turbo spin-echo axial and coronal T2-weighted images and axial fluid-attenuated inversion recovery (FLAIR) images; three examinations included T1-weighted three-dimensional magnetization-prepared rapid acquisition gradient-echo (3D MPRAGE) images. The signal intensity of the thalamus and pulvinar in every sequence was compared to that of the putamina.
RESULTS: In AGU, thalamic alterations were first detectable on T2-weighted images (25 examinations in 11 patients) from the age of 3 years 6 months, showing decreased signal intensity in 21 of 24 examinations. T1-weighted images (13 examinations) showed slightly increased thalamic signal intensity in five out of seven examinations from the age of 7 years, and PD images (19 examinations) showed decreased signal intensity from the age of 16 years (three examinations). The pulvinar showed decreased signal intensity on spin-echo T2-weighted images for 14 of 18 examinations or on FLAIR sequences for seven of seven examinations from the age of 6 years and 6 months, both in patients with and without bone marrow transplantation, but no pulvinar alterations were observable on T1 and PD images.
CONCLUSION: In AGU, the thalamus is affected. Pulvinar changes are visible only on T2-weighted images, and these may be the first changes reported in the group of lysosomal diseases.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18568562     DOI: 10.1080/02841850802065000

Source DB:  PubMed          Journal:  Acta Radiol        ISSN: 0284-1851            Impact factor:   1.990


  6 in total

1.  White Matter Microstructure and Subcortical Gray Matter Structure Volumes in Aspartylglucosaminuria; a 5-Year Follow-up Brain MRI Study of an Adolescent with Aspartylglucosaminuria and His Healthy Twin Brother.

Authors:  Tokola Anna; Brandstack Nina; Hakkarainen Antti; Salli Eero; Åberg Laura; Autti Taina
Journal:  JIMD Rep       Date:  2017-02-10

2.  Susceptibility-Weighted Imaging Findings in Aspartylglucosaminuria.

Authors:  A Tokola; M Laine; R Tikkanen; T Autti
Journal:  AJNR Am J Neuroradiol       Date:  2019-10-24       Impact factor: 3.825

3.  Effects of Age, Gender and Hemispheric Location on T2 Hypointensity in the Pulvinar at 3T.

Authors:  Matthew L White; Yan Zhang; Jason T Helvey; Fang Yu; Matthew F Omojola
Journal:  Neuroradiol J       Date:  2014-12-01

4.  Brain MRI findings in two Turkish pediatric patients with aspartylglucosaminuria.

Authors:  Ayşe Kartal; Kürşad Aydın
Journal:  Neuroradiol J       Date:  2016-08-22

5.  A 13-year follow-up of Finnish patients with Salla disease.

Authors:  Liisa E Paavola; Anne M Remes; Marika J Harila; Tarja T Varho; Tapio T Korhonen; Kari Majamaa
Journal:  J Neurodev Disord       Date:  2015-07-13       Impact factor: 4.025

6.  A cross-sectional natural history study of aspartylglucosaminuria.

Authors:  Kimberly Goodspeed; Daniel Horton; Andrea Lowden; Peter V Sguigna; Timothy Booth; Zhiyue J Wang; Veronica Bordes Edgar
Journal:  JIMD Rep       Date:  2022-07-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.